This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MAURICE J. COSTELLO, M.D.; CONSTANCE MILLETTE BUNCKE, M.D

AMA Arch Derm. 1955;72(4):348-352.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Promacetin^* (acetosulfone) has been used extensively, in relatively large doses and for long periods of time, in the treatment of leprosy.

Until recently, sulfapyridine has been the only effective treatment of dermatitis herpetiformis; notwithstanding its potential toxicity (agranulocytosis, etc.) it has remained for the past 15 years the treatment of choice because of its consistent beneficial results. The fact that it has been often used as a therapeutic test in this disease attests to its efficacy. We have been continually searching for a drug which would be equally effective therapeutically, but less toxic. Promacetin in tablets administered orally, we believe, has almost given us the answer in the control, but not in the permanent cure, of this inveterate dermatosis. Goldman reported its use in the treatment of this disease in 1952.⁴

The beneficial results obtained in the treatment of the following 12 . . . [Full Text PDF of this Article]

Author Affiliations
New York

From Bellevue Hospital, New York UniversityBellevue Medical Center, and St. Clare's Hospital.

Footnotes
Submitted for publication May 5, 1955.

Read before the Section on Dermatology and Syphilology at the 104th Annual Meeting of the American Medical Association, Atlantic City, June 9, 1955.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?